Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768440 · ClinicalTrials.gov registry record · Phase 3
Continuous Erector Spinae Block Versus Continuous Paravertebral Block
A Phase 3 study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 34
- Enrollment target
NCT03768440 is a Phase 3 study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 34 participants.
The verdict
NCT03768440, a Phase 3 study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 34 participants
- Enrollment target
Study Summary
Overall Aim: To evaluate the efficacy of continuous erector spinae block (ESB) versus continuous paravertebral block (PVB) for postoperative analgesia in children and adolescents undergoing surgical procedures via unilateral thoracotomy. Hypothesis: The investigators hypothesize that ESP block efficacy is not inferior to that of PVB with respect to pain control and consumed opiate equivalents at 24 hours postoperatively.
Interventions
- DRUG Ropivacaine
- PROCEDURE continuous erector spinae block (ESB)
- PROCEDURE continuous paravertebral block (PVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2025-02-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03768440
The ClinicalTrials.gov registry entry for NCT03768440 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ropivacaine is the first listed.
NCT03768440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03768440 about?
NCT03768440 is a clinical study titled "Continuous Erector Spinae Block Versus Continuous Paravertebral Block". Overall Aim: To evaluate the efficacy of continuous erector spinae block (ESB) versus continuous paravertebral block (PVB) for postoperative analgesia in children and adolescents undergoing surgical procedures via unilateral thoracotomy. Hypothesis: The investigators hypothesize that ESP block effi...
What is the current status of trial NCT03768440?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 34 participants. The study started on 2019-04-16. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT03768440?
The interventions under investigation include: Ropivacaine (DRUG), continuous erector spinae block (ESB) (PROCEDURE), continuous paravertebral block (PVB) (PROCEDURE).
Who is sponsoring clinical trial NCT03768440?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.